about
Quantitative analysis of 18F-NaF dynamic PET/CT cannot differentiate malignant from benign lesions in multiple myeloma.Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignancies.Fluorine-18-FDG PET/CT in a patient with angiomyolipoma: Response to mammalian target of rapamycin inhibitor therapy.Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab.The role of interim 18F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma.Longitudinal studies of the 18F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CTThe value of different 18F-FDG PET/CT baseline parameters in risk stratification of stage I surgical NSCLC patients
P50
Q41180773-5E025AD6-F0A9-46CA-9E9A-4955BAA2B508Q47668299-1CD951EF-D43B-4626-88B8-340C9F510785Q47702286-40E9D96B-9DE1-47FF-A4E0-83B57FE34B4CQ48329175-A95F0056-22AF-4044-AFEC-73C2033BE1D6Q52686599-8A803D23-A662-4EED-B059-CF2307291E69Q60652249-4C6947E8-74AE-4AEF-98C3-1D28480D7274Q91468823-EBA7FA22-8A8C-4CA1-BBE3-92A5B9A6C185
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Hoda Anwar
@ast
Hoda Anwar
@de
Hoda Anwar
@en
Hoda Anwar
@es
Hoda Anwar
@nl
Hoda Anwar
@sl
type
label
Hoda Anwar
@ast
Hoda Anwar
@de
Hoda Anwar
@en
Hoda Anwar
@es
Hoda Anwar
@nl
Hoda Anwar
@sl
prefLabel
Hoda Anwar
@ast
Hoda Anwar
@de
Hoda Anwar
@en
Hoda Anwar
@es
Hoda Anwar
@nl
Hoda Anwar
@sl
P227
P101
P106
P21
P214
2197153063189919320003
P227
1161695400
P31
P496
0000-0002-4071-5217
P569
2000-01-01T00:00:00Z
P7859
viaf-2197153063189919320003